Seven studies [20–24, 30, 31] assessed the association between STAT3/p-STAT3 expression and OS and PFS; 3 studies [27, 28, 33] only included patients with serous ovarian cancer, one study [31] only included patients with clear cell carcinoma. The gene discussed is STAT3; the disease is clear cell adenocarcinoma.